Cambridge Antibody Technology Group | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cambridge Antibody Technology Group

An SI Board Since December 1999

Posts	SubjectMarks	Bans
625	23	0

Emcee: Jongmans	Type: Unmoderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
550	Fred, I don't have the report in front of me, but I think the report cited t	rkrw	-	12/21/2004
549	<i>For now, I'm with ML on this (FWIW) - though I'm not looking fo	nigel bates	-	12/21/2004
548	Thanks guys - This today from ML: CATG Cambridge Antibody upgraded to Buy at Me	IRWIN JAMES FRANKEL	-	12/21/2004
547	Wilder: Ya, I was doing some more digging while you were posting. Thanks for you	fred hayes	-	12/21/2004
546	rkrw: Thanks for posting that. Bot a small position before the court case withou	fred hayes	-	12/21/2004
545	3% is the best rough cut net royalty rate. All you newcomers better do some mor	keokalani'nui	-	12/20/2004
544	I read a recent broker report that pegged net royalty to catg going from 0.7% to	rkrw	-	12/20/2004
543	I also thought that there were more potential drugs in the hopper relating to th	Madharry	-	12/20/2004
542	W: But aren't those old royalty estimates? They seem to keep increasing the	fred hayes	-	12/20/2004
541	Market Cap, correct. Previous est of net peak H royalties, before lawsuit, were	keokalani'nui	-	12/20/2004
540	Maybe someone can help me. MC $590M EV $330M Royalties will be 5-6%, call it 5	IRWIN JAMES FRANKEL	-	12/20/2004
539	I guess I would have too?!? But it is time for another serious look at holding	keokalani'nui	-	12/20/2004
538	Opportunity cost - I'd have done a great deal better following Wilder a year	nigel bates	-	12/20/2004
537	I reentered and bought a little too. wish i would have had your conviction of vi	Madharry	-	12/20/2004
536	(FWIW), I was expecting a 25 - 30% pop on this news. I bought some more just be	nigel bates	-	12/20/2004
535	Ruling rests on facts broadly derived from all of the evidence and legal constru	keokalani'nui	-	12/20/2004
534	Yes, but were they sufficiently confident of victory 12 months ago to have forwa	nigel bates	-	12/20/2004
533	Congrats Nigel. The good guys win! eom	fred hayes	-	12/20/2004
532	CAT wins on all three of its separate arguments - <i>I have also consider	nigel bates	-	12/20/2004
531	<pre>CAMBRIDGE ANTIBODY TECHNOLOGY PREVAILS IN PROCEEDINGS IN HIGH COURT R	nigel bates	-	12/20/2004
530	<i>"is not in a position to rewrite the contract..." </i>	keokalani'nui	-	12/17/2004
529	UPDATE 1-UK's CAT says Abbott drug case decision due Dec.20 Fri Dec 17, 2004	nigel bates	-	12/17/2004
528	New 20-F just filed. sec.gov	keokalani'nui	-	12/16/2004
527	Omitted to post the Serono / Micromet deal to the thread - Message 20834195 (3	nigel bates	-	12/16/2004
526	from this week's (thanks, R!) BioCentury..... CAT's pipeline <pre&g	scaram(o)uche	-	12/5/2004

Go to reply# or date (mm/dd/yy):